Search research articles
Contact Us
Filters
Showing results (171-180 of 252) with videos related to
Page
of 26
Sort By:
British Journal of Haematology
|
April 14, 2016
Outcomes of MYC-associated lymphomas after R-CHOP with and without consolidative autologous stem cell transplant: subset analysis of randomized trial intergroup SWOG S9704
Soham D Puvvada, Patrick J Stiff, Michael Leblanc, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 20, 2005
Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group
Ralph M Meyer, Mary K Gospodarowicz, Joseph M Connors, et al.
Plos Neglected Tropical Diseases
|
October 2, 2020
Vitamin A supplementation boosts control of antibiotic-resistant Salmonella infection in malnourished mice
Annica R Stull-Lane, Kristen L Lokken-Toyli, Vladimir E Diaz-Ochoa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 15, 2009
The novel expanded porphyrin, motexafin gadolinium, combined with [90Y]ibritumomab tiuxetan for relapsed/refractory non-Hodgkin's lymphoma: preclinical findings and results of a phase I trial
Andrew M Evens, William G Spies, Irene B Helenowski, et al.
JAMA Oncology
|
March 17, 2023
Pembrolizumab Added to Ifosfamide, Carboplatin, and Etoposide Chemotherapy for Relapsed or Refractory Classic Hodgkin Lymphoma: A Multi-institutional Phase 2 Investigator-Initiated Nonrandomized Clinical Trial
Locke J Bryan, Carla Casulo, Pamela B Allen, et al.
The New England Journal of Medicine
|
December 14, 2011
ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma
Ralph M Meyer, Mary K Gospodarowicz, Joseph M Connors, et al.
Blood
|
September 29, 2020
Pembrolizumab followed by AVD in untreated early unfavorable and advanced-stage classical Hodgkin lymphoma
Pamela B Allen, Hatice Savas, Andrew M Evens, et al.
Plos One
|
March 26, 2013
Nano-encapsulation of arsenic trioxide enhances efficacy against murine lymphoma model while minimizing its impact on ovarian reserve in vitro and in vivo
Richard W Ahn, Susan L Barrett, Meera R Raja, et al.
ANZ Journal of Surgery
|
September 7, 2016
Laparoscopic or open appendicectomy for suspected appendicitis in pregnancy and evaluation of foetal outcome in Australia
Nicole N Winter, Glenn D Guest, Michael Bozin, et al.
Cancers
|
May 14, 2022
Outcomes of Cancer Patients with COVID-19 in a Hospital System in the Chicago Metropolitan Area
Alain Mina, Carlos Galvez, Reem Karmali, et al.
Page
of 26
Search research articles
Search
Showing results (171-180 of 252) with videos related to
Sort By:
Page
of 26
British Journal of Haematology
|
April 14, 2016
Outcomes of MYC-associated lymphomas after R-CHOP with and without consolidative autologous stem cell transplant: subset analysis of randomized trial intergroup SWOG S9704
Soham D Puvvada, Patrick J Stiff, Michael Leblanc, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 20, 2005
Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group
Ralph M Meyer, Mary K Gospodarowicz, Joseph M Connors, et al.
Plos Neglected Tropical Diseases
|
October 2, 2020
Vitamin A supplementation boosts control of antibiotic-resistant Salmonella infection in malnourished mice
Annica R Stull-Lane, Kristen L Lokken-Toyli, Vladimir E Diaz-Ochoa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 15, 2009
The novel expanded porphyrin, motexafin gadolinium, combined with [90Y]ibritumomab tiuxetan for relapsed/refractory non-Hodgkin's lymphoma: preclinical findings and results of a phase I trial
Andrew M Evens, William G Spies, Irene B Helenowski, et al.
JAMA Oncology
|
March 17, 2023
Pembrolizumab Added to Ifosfamide, Carboplatin, and Etoposide Chemotherapy for Relapsed or Refractory Classic Hodgkin Lymphoma: A Multi-institutional Phase 2 Investigator-Initiated Nonrandomized Clinical Trial
Locke J Bryan, Carla Casulo, Pamela B Allen, et al.
The New England Journal of Medicine
|
December 14, 2011
ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma
Ralph M Meyer, Mary K Gospodarowicz, Joseph M Connors, et al.
Blood
|
September 29, 2020
Pembrolizumab followed by AVD in untreated early unfavorable and advanced-stage classical Hodgkin lymphoma
Pamela B Allen, Hatice Savas, Andrew M Evens, et al.
Plos One
|
March 26, 2013
Nano-encapsulation of arsenic trioxide enhances efficacy against murine lymphoma model while minimizing its impact on ovarian reserve in vitro and in vivo
Richard W Ahn, Susan L Barrett, Meera R Raja, et al.
ANZ Journal of Surgery
|
September 7, 2016
Laparoscopic or open appendicectomy for suspected appendicitis in pregnancy and evaluation of foetal outcome in Australia
Nicole N Winter, Glenn D Guest, Michael Bozin, et al.
Cancers
|
May 14, 2022
Outcomes of Cancer Patients with COVID-19 in a Hospital System in the Chicago Metropolitan Area
Alain Mina, Carlos Galvez, Reem Karmali, et al.
Page
of 26